|

China: Signs of improvement in real activity – Standard Chartered

Standard Chartered analysts suggest that China’s November growth data has beaten the market expectations with industrial production (IP) growth surging to 6.2% YoY from 4.7% in October, partly on seasonal factors.

Key Quotes

“Services-sector growth edged up to 6.8% y/y from 6.6% prior. The labour market remains resilient, with the surveyed city unemployment rate unchanged at 5.1%. Retail sales growth picked up to 8.0% y/y from 7.2% in October, driven by higher inflation and Singles’ Day sales promotions.”

“Fixed asset investment (FAI) growth accelerated to 5.2% y/y from 3.7% in October on resilient real-estate investment, while infrastructure investment remained soft and manufacturing investment weakened. Overall, growth momentum appears to have improved in November, supporting our forecast of a tentative stabilisation in Q4-2019.”

“The recent Central Economic Work Conference (CEWC) confirmed that the top priority for 2020 is to achieve “a moderately prosperous society”. Furthermore, the ‘phase one’ trade deal between China and the US reduces the tariff drag on China’s GDP growth in 2020. These support our above-consensus GDP forecast of 6.1% for 2020.”

“We expect the government to set a growth target at around 6% for 2020, providing policy support for a slightly higher growth rate. This includes a proactive fiscal policy, with a shift in fiscal support from tax cuts to spending, and an accommodative monetary policy to support expansionary fiscal policy.”

“We expect three reserve requirement ratio (RRR) cuts of 50bps each, or an equivalent liquidity injection through targeted RRR cuts or central bank lending, in the first three quarters of 2020, as well as two 10bps medium-term lending facility (MLF) rate cuts in Q1 and Q2 to facilitate a further lowering of the loan prime rate (LPR).”

Author

Sandeep Kanihama

Sandeep Kanihama

FXStreet Contributor

Sandeep Kanihama is an FX Editor and Analyst with FXstreet having principally focus area on Asia and European markets with commodity, currency and equities coverage. He is stationed in the Indian capital city of Delhi.

More from Sandeep Kanihama
Share:

Editor's Picks

EUR/USD struggles to hold above 1.1800 ahead of US data

EUR/USD finds it difficult to gather recovery momentum and retreats below 1.1800 in the second half of the day on Thursday. The US Dollar (USD) stays resilient against its peers after the hawkish surprise in FOMC Minutes, weighing on the pair ahead of the next batch of US data.

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold retreats from daily highs, trades below $5,000

Gold finds it difficult to stabilize above the $5,000 psychological mark on Thursday and trades slightly below this level in the early American session. Escalating geopolitical tensions in the Middle East help XAU/USD hold its ground, while the broad-based USD strength caps the pair's upside.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.